Printer Friendly
The Free Library
14,679,626 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Hi-Tech Pharmacal Introduces New Branded Products for People with Diabetes.


Business Editors/Health/Medical Writers

AMITYVILLE, N.Y.--(BUSINESS WIRE)--July 30, 2003

Hi-Tech Pharmacal Co., Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: HITK) - announced today that its Health Care Products Division (HCP HCP,
n healthcare provider, a professional who specializes in treating and managing a person's general or specific health needs.
) recently launched several new products and line extensions for people with diabetes.

Through its partnership with Medifast, HCP launched its clinically tested DiabetiTrim(R), a nutritionally-balanced weight management shake for people with diabetes. The exclusive DiabetiTrim(R) formula is backed by 20 years of research, including studies at Johns Hopkins Bloomberg School of Public Health The Johns Hopkins Bloomberg School of Public Health is part of Johns Hopkins University in Baltimore, Maryland, U.S. It was the first institution of its kind in the world.

Founded in 1916 by William H. Welch and John D.
, and experience in weight management nutrition. DiabetiTrim(R) combines a low-calorie content with a high proportion of protein, contains 24 essential vitamins and minerals, is rich in calcium and dietary fiber dietary fiber
n.
Coarse, indigestible plant matter, consisting primarily of polysaccharides, that when eaten stimulates intestinal peristalsis.
, and is low in sugars and fat.

Gary April, President of the Health Care Products Division, commented: "The number of Americans diagnosed with diabetes jumped 49% over for the last decade. About 17million people now suffer from the disease which is largely associated with obesity. "DiabetiTrim(R) presents an opportunity for people with diabetes to have delicious drinks, snacks, and meals to help them feel full and help reach their weight objectives. As we all know, one of the biggest challenges for people with diabetes is to lose weight and keep it off. Great tasting, nutritionally balanced products like DiabetiTrim(R) help in losing weight, but more importantly helps the individual take control. "

HCP also launched three new products under its DiabetiDerm(R) skin care line: DiabetiDerm(R) Massage Stimulator Roll-On and DiabetiDerm(R) Gentle Cleansing Lotion - both containing advanced formulas with L-Arginine - and DiabetiDerm(R) Sunscreen sunscreen /sun·screen/ (-skren) a substance applied to the skin to protect it from the effects of the sun's rays.

sun·screen
n.
 with a special moisturizing formula. The L-Arginine has been clinically demonstrated to improve micro-circulation in the skin, increasing sensation in the leg and foot areas.

HCP also introduced DiabetiSweet(R) Brown sugar substitute to supplement the original DiabetiSweet(R), which unlike other sugar substitutes, maintains its taste at high temperatures and is ideal for baking and cooking, Mr. April continued: "We are also pleased to announce that according to according to
prep.
1. As stated or indicated by; on the authority of: according to historians.

2. In keeping with: according to instructions.

3.
 the 2003 Pharmacy Times OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 Recommendation Survey, an overwhelming 45.3% of pharmacists recommend Diabetic Tussin(R), the number one selling sugar free cough syrup cough syrup
n.
A sweetened medicated liquid taken orally to ease coughing.
. In the sugar free cough category, Diabetic Tussin(R) was recommended by pharmacists twice more often than competing products."

Hi-Tech is a specialty pharmaceutical company developing, manufacturing and marketing branded and generic prescription and OTC products for the general healthcare industry. The Company specializes in difficult to manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic, otic and inhalation products. The company's Health Care Products Division is a leading developer and marketer of branded prescription and OTC products for the diabetes marketplace.

Statements concerning future results in this release may constitute forward-looking statements within the meaning of the safe harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. These statements are based on current expectation and the current economic environment. These statements involve a number risks and uncertainties, including but not limited to the impact of competitive products and pricing, product demand and market acceptance, new product development, reliance on key strategic alliances, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission. Actual results could differ materially from those expressed or implied in the forward-looking statements and these statements are not guarantees of the future performance.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 30, 2003
Words:567
Previous Article:Wellspring Expands Operations -- Moves to New, Larger Facility; Submetering Leader's Revenues Up 200% from '02.
Next Article:Tengtu Announces That It Has Moved Closer To Completing Its Plans To Connect 100,000 Schools And 50 Million Students By 2005.



Related Articles
Hi-Tech Pharmacal Announces Expanded Internet Strategy for its Diabetic Product Line.
Hi-Tech Pharmacal Announces Agreement with Diabetic.com.
Antacid/Calcium Supplement.(Brief Article)
Hi-Tech Pharmacal Signs Agreement for Distribution of Diabetic Tussin C in Puerto Rico.
Hi-Tech Signs International Distribution Agreement.
Hi-Tech Pharmacal Announced 39% Increase in Sales and 82% Increase in Net Income for Three Months Ended October 31, 2002.
Hi-Tech Pharmacal Reports 63% Increase in Net Income for the Fiscal Year Ended April 30, 2003.
Hi-Tech Pharmacal Enters into Agreement with Syncom Pharmaceuticals to Promote Diabetic Tussin C to Physicians.
Hi-Tech Pharmacal Ranked #30 among Forbes' 200 up and Coming Companies.
Veneer.(PRODUCT NEWS: SUPPLIES)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles